![]() Breakthrough Behavioral Breakthrough connects people with mental health providers for online counseling and telepsychiatry. | UpLift UpLift Health is a mental health company that provides a cognitive-behavioral therapy-based app. | The Difference The Difference is a company offering behavioral health services via phone, app, or smart speaker. | ![]() Karuna Therapeutics Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions. | ||
Founding Date | Founding Date 2009 | Founding Date 2000 | Founding Date 2017 | Founding Date 2017 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Redwood City, US HQ | Locations Helsingfors, FI HQ Frankfurt Am Main, DE Madison, US | Locations HQ | Locations New York, US HQ | Locations Boston, US HQ Boston, US Carmel, US |
Employees | Employees 14 | Employees 40 | Employees 9 | Employees 10 | Employees 1919% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 40 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 12.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €11m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $654k (FY, 2023) |
Net income | Net income N/A | Net income €573k (FY, 2025) | Net income N/A | Net income N/A | Net income ($433.7m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 11.7m | Total funding raised N/A | Total funding raised $ 1m | Total funding raised N/A | Total funding raised $ 118.7m |
Nexstim is a company focusing on therapies and diagnostics for brain diseases and disorders.
View companyUpLift Health is a mental health company that provides a cognitive-behavioral therapy-based app.
View companyThe Difference is a company offering behavioral health services via phone, app, or smart speaker.
View company
Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions.
View company